Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19. - Files DC; Tacke F; O'Sullivan A; Dorr P; Ferguson WG; Powderly WG (PLoS pathogens, 2022)